Here is the well known example of Prana being on the other side of a patent dispute where Greek pharma PN Gerolymatos held the patent for clioquinol for stomach bugs and Prana patented it for neurodegeneration for its metal chelating abilities. As I remember they called in the pharma for consultation and the pharma patented it as well. Maybe even first. Then Prana was in a dispute to register their IP. I guess that is where GK learned it is best to keep secrets till the patents are done. GK was there then, so is no stranger to a dispute of this nature. Dianne Angus was also there when it was settled in 2004. https://www.labonline.com.au/content/life-scientist/news/prana-settles-clioquinol-dispute-16898714 It has been known for some time that 8-OHQs can be effective against antibiotic resistant bacteria. As I posted above 2014: The activity of 8HQ mostly was observed for resistant pathogens, gram- positive bacteria e.g. Staphylococcus aureus, Enterococcus faecalis and diploid fungus, Candida albicans. https://scialert.net/fulltextmobile/?doi=ijp.2013.170.175
